Neurogene Vs. Aligos Therapeutics Industry Stock Comparison

Sell

18

NGNE
Neurogene

Last Price:

$23.75

Seasonality Move:

23.27%

Buy

65

ALGS
Aligos Therapeutics

Last Price:

$41.87

Seasonality Move:

-16.03%

Sell

18

Neurogene (NGNE) is a Sell

Is Neurogene a Buy, Sell or Hold?

The current Neurogene [NGNE] share price is $24.10. The Score for NGNE is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
NGNE is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
This Score is currently showing an extreme reading that indicates risk could be especially high.

Buy

65

Aligos Therapeutics (ALGS) is a Buy

Is Aligos Therapeutics a Buy, Sell or Hold?

The current Aligos Therapeutics [ALGS] share price is $43.37. The Score for ALGS is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
ALGS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

NGNE Stock Price Chart

What is Neurogene's stock price today?

The Neurogene share price today is $24.10

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NGNE is experiencing slight buying pressure.

ALGS Stock Price Chart

What is Aligos Therapeutics's stock price today?

The Aligos Therapeutics share price today is $43.37

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.

NGNE Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-2.93	Sell
Relative Strength Index (14 RSI):	44.24	Sell
Chaikin Money Flow:	41475	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(20.12 - 25.24)	Buy
Bollinger Bands (100):	(25.41 - 49.75)	Sell

ALGS Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	5.71	Buy
Relative Strength Index (14 RSI):	81.52	Buy
Chaikin Money Flow:	630913	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(22.74 - 36.8)	Buy
Bollinger Bands (100):	(6.83 - 25.23)	Buy

NGNE Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	23.07	Buy
20-day SMA:	23.33	Buy
50-day SMA:	35.82	Sell
200-day SMA:	37.67	Sell
8-day EMA:	23.08	Buy
20-day EMA:	24.75	Sell
50-day EMA:	31.09	Sell
200-day EMA:	34.66	Sell

ALGS Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	37.61	Buy
20-day SMA:	32.22	Buy
50-day SMA:	20.6	Buy
200-day SMA:	16.51	Buy
8-day EMA:	38.12	Buy
20-day EMA:	32.66	Buy
50-day EMA:	24.43	Buy
200-day EMA:	18.11	Buy

Neurogene Earnings Growth & NGNE Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.04 per share.

Aligos Therapeutics Earnings Growth & ALGS Earnings Dates

Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.

Neurogene Technical Analysis

	Dec 12	Dec 13	Dec 16	Dec 17	Dec 18	Dec 19	Dec 20	Dec 23	Dec 24	Dec 26
	Dec
	12	13	16	17	18	19	20	23	24	26
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Aligos Therapeutics Technical Analysis

	Dec 12	Dec 13	Dec 16	Dec 17	Dec 18	Dec 19	Dec 20	Dec 23	Dec 24	Dec 26
	Dec
	12	13	16	17	18	19	20	23	24	26
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):